However, with regards to the BPH components measurements, i.e. PV, Qmax, serum PSA levels and I-PSS-QoL, there were no significant differences between subjects with and without MetS at baseline (all p > 0.05). The gene discussed is KLK3; the disease is metabolic syndrome.